Haemonetics (STU:HAZ) Cyclically Adjusted Book per Share: €15.38 (As of Mar. 2026)


STU:HAZ Haemonetics Corp STU:HAZ
81 GF Score
Price €65.50
GF Value €74.38
! 4 Warning Signs
View Full Analysis

What is Haemonetics Cyclically Adjusted Book per Share?

Haemonetics STU:HAZ +0.77% 81 Cyclically Adjusted Book per Share is €15.38 as of Mar. 2026. GuruFocus rates STU:HAZ with a GF Score™ of 81/100 and a GF Value™ of €74.38. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Haemonetics's adjusted book value per share for the three months ended in Mar. 2026 was €15.221. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €15.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Haemonetics's average Cyclically Adjusted Book Growth Rate was 2.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Haemonetics was 11.70% per year. The lowest was 1.40% per year. And the median was 7.10% per year.

As of today (2026-07-08), Haemonetics's current stock price is €65.50. Haemonetics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €15.38. Haemonetics's Cyclically Adjusted PB Ratio of today is 4.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Haemonetics was 9.02. The lowest was 2.16. And the median was 4.62.


Haemonetics  (STU:HAZ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Haemonetics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=65.50/15.38
=4.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Haemonetics was 9.02. The lowest was 2.16. And the median was 4.62.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Haemonetics Cyclically Adjusted Book per Share Related Terms


Haemonetics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Haemonetics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haemonetics Cyclically Adjusted Book per Share Chart

Haemonetics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.37 14.97 15.62 15.80 15.38

Haemonetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.80 14.69 14.59 14.68 15.38

STU:HAZ vs ITGR, IRTC, ESTA: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Haemonetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haemonetics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Haemonetics's Cyclically Adjusted PB Ratio falls into.


STU:HAZ
81GF Score
Haemonetics Corp STU:HAZ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haemonetics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Haemonetics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.221/330.2130*330.2130
=15.221

Current CPI (Mar. 2026) = 330.2130.

Haemonetics Quarterly Data

Book Value per Share CPI Adj_Book
201606 12.473 241.018 17.089
201609 12.952 241.428 17.715
201612 14.101 241.432 19.286
201703 13.234 243.801 17.925
201706 13.095 244.955 17.653
201709 12.757 246.819 17.067
201712 13.023 246.524 17.444
201803 11.658 249.554 15.426
201806 11.173 251.989 14.641
201809 11.643 252.439 15.230
201812 11.086 251.233 14.571
201903 11.585 254.202 15.049
201906 10.301 256.143 13.280
201909 10.474 256.759 13.470
201912 10.262 256.974 13.187
202003 10.558 258.115 13.507
202006 10.665 257.797 13.661
202009 11.184 260.280 14.189
202012 11.633 260.474 14.748
202103 12.082 264.877 15.062
202106 11.016 271.696 13.389
202109 11.629 274.310 13.999
202112 12.654 278.802 14.987
202203 13.310 287.504 15.287
202206 14.203 296.311 15.828
202209 14.550 296.808 16.188
202212 14.522 296.797 16.157
202303 15.144 301.836 16.568
202306 15.739 305.109 17.034
202309 16.503 307.789 17.705
202312 17.033 306.746 18.336
202403 17.389 312.332 18.385
202406 16.443 314.175 17.282
202409 15.717 315.301 16.460
202412 17.240 315.605 18.038
202503 15.747 319.799 16.260
202506 15.884 322.561 16.261
202509 15.477 324.800 15.735
202512 16.622 324.054 16.938
202603 15.221 330.213 15.221

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €15.38 mean?
Haemonetics (STU:HAZ) has a Cyclically Adjusted Book per Share of €15.38 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Haemonetics and its competitors.
Is Haemonetics' Cyclically Adjusted Book per Share too high?
Haemonetics' current Cyclically Adjusted Book per Share is €15.38. Overall, Haemonetics has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Haemonetics' Cyclically Adjusted Book per Share compare to ITGR and IRTC?
Haemonetics' Cyclically Adjusted Book per Share of €15.38 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Haemonetics and its competitors. Haemonetics's current Cyclically Adjusted Book per Share is €15.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haemonetics stock overvalued right now?
Haemonetics (STU:HAZ) has a current Cyclically Adjusted Book per Share of €15.38. The stock's GF Value™ is €74.38, compared to a current price of €65.50 — trading 11.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is €15.38. Haemonetics' overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Haemonetics (STU:HAZ), the current Cyclically Adjusted Book per Share is €15.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haemonetics (STU:HAZ) Overvalued in 2026?

Based on GuruFocus' analysis, Haemonetics stock appears to be undervalued. The current stock price of €65.50 is trading 11.9% below its estimated GF Value™ of €74.38.

Key valuation signals for STU:HAZ:

  • Cyclically Adjusted Book per Share: €15.38
  • GF Value™: €74.38 vs. price of €65.50 (11.9% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the STU:HAZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haemonetics Business Description

Other Exchanges HAE:USA
Address 125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
81GF Score

Get the complete analysis for STU:HAZ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.50
Price
€74.38
GF Value